499 related articles for article (PubMed ID: 27558013)
1. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.
Ashouri E; Norman PJ; Guethlein LA; Han AS; Nemat-Gorgani N; Norberg SJ; Ghaderi A; Parham P
HLA; 2016 Sep; 88(3):87-99. PubMed ID: 27558013
[TBL] [Abstract][Full Text] [Related]
2. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors.
Alicata C; Ashouri E; Nemat-Gorgani N; Guethlein LA; Marin WM; Tao S; Moretta L; Hollenbach JA; Trowsdale J; Traherne JA; Ghaderi A; Parham P; Norman PJ
Front Immunol; 2020; 11():556. PubMed ID: 32300348
[TBL] [Abstract][Full Text] [Related]
3. Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.
Shen Y; Cao D; Li Y; Kulski JK; Shi L; Jiang H; Ma Q; Yu J; Zhou J; Yao Y; Shi L
J Immunol Res; 2014; 2014():565296. PubMed ID: 24995346
[TBL] [Abstract][Full Text] [Related]
4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
5. Diversity of KIR, HLA Class I, and Their Interactions in Seven Populations of Sub-Saharan Africans.
Nemat-Gorgani N; Guethlein LA; Henn BM; Norberg SJ; Chiaroni J; Sikora M; Quintana-Murci L; Mountain JL; Norman PJ; Parham P
J Immunol; 2019 May; 202(9):2636-2647. PubMed ID: 30918042
[No Abstract] [Full Text] [Related]
6. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
7. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
8. Genetic study of KIR and HLA ligands in 235 individuals from Northeastern Thailand.
Chaisri S; Leelayuwat C; Romphruk A
Hum Immunol; 2017; 78(5-6):395-396. PubMed ID: 28431957
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
10. Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B.
Older Aguilar AM; Guethlein LA; Hermes M; Walter L; Parham P
Immunogenetics; 2011 Sep; 63(9):577-85. PubMed ID: 21614583
[TBL] [Abstract][Full Text] [Related]
11. Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Marin WM; Norberg SJ; Ashouri E; Jayaraman J; Wroblewski EE; Trowsdale J; Rajalingam R; Oksenberg JR; Chiaroni J; Guethlein LA; Traherne JA; Ronaghi M; Parham P
Am J Hum Genet; 2016 Aug; 99(2):375-91. PubMed ID: 27486779
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
13. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
14. An improved method for HLA-B and -C supratyping.
Biassoni R; Malnati S; Vanni I; Raso A; Sironi F; Broccolo F; Garbarino L; Mazzocco M; Montera M; Larghero P; Di Marco E; Ugolotti E
J Immunol Methods; 2015 Nov; 426():29-34. PubMed ID: 26232127
[TBL] [Abstract][Full Text] [Related]
15. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
16. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks.
Capittini C; Tinelli C; Guarene M; Pasi A; Badulli C; Sbarsi I; Garlaschelli F; Cremaschi AL; Pizzochero C; Monti C; Salvaneschi L; Martinetti M
Genes Immun; 2012 Sep; 13(6):452-7. PubMed ID: 22573115
[TBL] [Abstract][Full Text] [Related]
17. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
18. Distinctive KIR and HLA diversity in a panel of north Indian Hindus.
Rajalingam R; Krausa P; Shilling HG; Stein JB; Balamurugan A; McGinnis MD; Cheng NW; Mehra NK; Parham P
Immunogenetics; 2002 Mar; 53(12):1009-19. PubMed ID: 11904677
[TBL] [Abstract][Full Text] [Related]
19. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
20. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
